Reply

James R. Duncan; Michael R. Lieber; Noritaka Adachi; Richard L. Wahl

doi:10.2967/jnumed.118.218321

Reply

James R. Duncan, Michael R. Lieber, Noritaka Adachi, Richard L. Wahl

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1780-1781
Number of pages	2
Journal	Journal of Nuclear Medicine
Volume	59
Issue number	11
DOIs	https://doi.org/10.2967/jnumed.118.218321
State	Published - Nov 1 2018

Access to Document

10.2967/jnumed.118.218321

Cite this

@article{bcea80e414e94cf9b6b82f9d046dcc53,

title = "Reply",

author = "Duncan, {James R.} and Lieber, {Michael R.} and Noritaka Adachi and Wahl, {Richard L.}",

note = "Funding Information: James R. Duncan reports personal fees from Bayer HealthCare LLC, Institute for Healthcare Improvement, and Ascension Health and other from Novation and Washington State Hospital Association, all of which are outside the submitted work. Richard L. Wahl reports consulting fees from Nihon Medi Physics and from Clarity Pharmaceuticals Inc; research grants from White Rabbit AI and Actinium Pharmaceuticals; and travel reimbursement from Siemens Medical and GE Medical, all of which are outside the submitted work. These relationships are managed by the Washington University Conflict of Interest Committee. No other potential conflict of interest relevant to this article was reported.",

year = "2018",

month = nov,

day = "1",

doi = "10.2967/jnumed.118.218321",

language = "English",

volume = "59",

pages = "1780--1781",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

number = "11",

}

TY - JOUR

T1 - Reply

AU - Duncan, James R.

AU - Lieber, Michael R.

AU - Adachi, Noritaka

AU - Wahl, Richard L.

N1 - Funding Information: James R. Duncan reports personal fees from Bayer HealthCare LLC, Institute for Healthcare Improvement, and Ascension Health and other from Novation and Washington State Hospital Association, all of which are outside the submitted work. Richard L. Wahl reports consulting fees from Nihon Medi Physics and from Clarity Pharmaceuticals Inc; research grants from White Rabbit AI and Actinium Pharmaceuticals; and travel reimbursement from Siemens Medical and GE Medical, all of which are outside the submitted work. These relationships are managed by the Washington University Conflict of Interest Committee. No other potential conflict of interest relevant to this article was reported.

PY - 2018/11/1

Y1 - 2018/11/1

UR - http://www.scopus.com/inward/record.url?scp=85055912438&partnerID=8YFLogxK

U2 - 10.2967/jnumed.118.218321

DO - 10.2967/jnumed.118.218321

M3 - Letter

C2 - 30262519

AN - SCOPUS:85055912438

VL - 59

SP - 1780

EP - 1781

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 11

ER -

Reply

Access to Document

Other files and links

Cite this